$PG — AVOID 📊 | 6 MONTHS THESIS

$PG — AVOID 📊 | 6 MONTHS THESIS 🎯 Q1 2026 | Rev $21.2B | EPS $1.59 vs $1.56 🟢 | Margin 21.6% 💡 The market expects stable, low-growth earnings; the small beat does not alter the long-term trajectory. Quant rank (1st percentile cross-sectional) indicates the stock is overbought or overvalued relative to peers, and there is no variant perception driving a repricing—expectations are adequately met, not mispriced. 📉 Reward/risk: 1.2:1 🏢 Business Quality: 9/10 📊 Valuation: rich — likely 25–28x forward earnings, above historical average and peer staples, with low FCF yield; quant rank confirms overvaluation. 🔮 Catalyst: Q1 2026 earnings beat (reported March 31, 2026) 💰 Entry: $149.54, stop $145, target $155 📊 Our read: AVOID. Full analysis → https://stockduty.xyz/s/PG0625

🎯 Q1 2026 | Rev $21.2B | EPS $1.59 vs $1.56 🟢 | Margin 21.6%